Retatrutide Peptide In 10 Vials

Description

Key Benefits & Clinically Supported Outcomes

✅ Dramatic Weight Loss – Achieve up to 16.94% bodyweight reduction at 12mg doses, with lower doses (4–8mg) still yielding 7.9–16.8% reductions.
✅ Glycemic Control – Reduces HbA1c by 1.39–2.02% in 24 weeks, outperforming placebo and dulaglutide in clinical trials.
✅ Triple-Agonist Action – Simultaneously activates GIP, GLP-1, and glucagon receptors to optimize appetite suppression, fat oxidation, and energy expenditure.
✅ Metabolic Flexibility – Enhances insulin sensitivity and mitochondrial efficiency, supporting long-term metabolic health.
✅ Research-Grade Purity – ≥98.98% HPLC-verified peptide with lyophilized stability, ensuring reliable experimental results.

Why Choose Retatrutide Vials?

• Clinical Credibility: Phase 2 trial data show superiority over GLP-1 monotherapies, with robust weight loss and glucose-lowering efficacy.
• Dose Flexibility: Scalable dosing from 2.5mg (starting) to 15mg (max), ideal for incremental study designs.
• Stack Synergy: Compatible with semaglutide or tirzepatide for comparative metabolic research.
• Long-Term Stability: Lyophilized powder retains potency for 24+ months at -20°C; reconstituted solution stable for 3–4 weeks refrigerated.

Usage Guidelines

• Reconstitution: Mix with 1–2ml bacteriostatic water. Inject slowly along vial walls to minimize foaming.
• Dosing Protocol:
  • Starting Dose: 2.5mg/week for 2–4 weeks to assess tolerability.
  • Escalation: Increase by 2.5mg every 4 weeks, max 15mg/week for advanced studies.
  • Maintenance: Sustain at 5–10mg/week post-goal achievement.
• Administration: Subcutaneous or intramuscular injection; avoid intravenous use.

Act Now—Limited Stock!
With 10 vials of Retatrutide, you’re equipped to pioneer cutting-edge metabolic research. Click “Add to Cart” to secure your supply and advance your studies today!